King Tube Versus iGel: Which Supraglottic Airway will Reign Supreme? (Oct 2023)

The use of supraglottic airway devices during the resuscitation of out-of-hospital cardiac arrest (OHCA) patients is increasing across the United States and worldwide. The two most commonly used supraglottic airway devices in the United States are the King Laryngeal Tube (King-LT) and the iGel. It is unknown if design differences for the KING-LT and the iGel may translate to differential first pass insertion success or ventilation effectiveness and therefore impact patient outcomes. Join us on the next PCRF Journal Club as we review a study from the CARES surveillance group that compares the neurologic outcomes of OHCA patients managed with the King Laryngeal Tube (King LT) to the neurologic outcomes of patients managed with the iGel. Article: https://pubmed.ncbi.nlm.nih.gov/37120129/